Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$334,784
-$58,560 QoQ
Shares Held
13,903
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,049
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northstar Group, Inc. holds $22,517,694 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,370 | $10,506,738 | |
| 2 | ABBV |
AbbVie Inc.
|
22,876 | $5,756,516 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,202 | $3,109,957 | |
| 4 | LLY |
ELI LILLY & Co
|
993 | $1,191,034 | |
| 5 | AMGN |
Amgen Inc
|
1,468 | $531,592 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,442 | $428,808 | |
| 7 | NVS |
Novartis AG
|
2,729 | $427,688 | |
| 8 | PFE |
Pfizer Inc
This page
|
13,903 | $334,784 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,784 | 13,903 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $393,344 | 14,008 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $354,351 | 14,231 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $384,518 | 15,091 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $368,351 | 15,196 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $400,093 | 15,789 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $405,272 | 15,276 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $382,760 | 13,226 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $486,796 | 17,398 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $496,530 | 17,893 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $515,139 | 17,893 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $713,221 | 21,502 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $797,349 | 21,738 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $878,872 | 21,541 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,081,932 | 21,115 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $927,011 | 21,184 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $1,116,916 | 21,303 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,101,303 | 21,273 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,275,952 | 21,608 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $659,730 | 15,339 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $590,963 | 15,091 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $508,415 | 14,033 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $508,603 | 13,817 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $528,809 | 14,409 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $412,118 | 12,603 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $402,581 | 12,334 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||